Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $180.7 million versus the consensus estimate of $175.44 million.

Full Year 2021 Outlook

The Company expects 2021 net sales to increase 2 to 4 percent, on a constant currency basis, compared to 2020 and earn between $1.10 and $1.25 of adjusted diluted earnings per share. This outlook reflects certain key assumptions, which are listed below:

• The Company expects the foreign currency translation impact to be even to 1 percent favorable compared to the prior year.
• The adjusted effective tax rate is anticipated to be between 25 and 27 percent.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.